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ABSTRACT
Objective: To determine the vaginal-rectal colonization rate with group A streptococci in late preg-
nancy.
Methods: All patients delivering at a northern New England hospital over a 38 month period had
35-37 week vaginal-rectal swabs cultured for group A and group B streptococci, using selective
media and slide agglutination.
Results: Six thousand nine hundred forty-four screening cultures were obtained. Among these
1,393 were positive for group B streptococci and 2 for group A streptococci, yielding colonization
rates of 20.1% and 0.03%, respectively.
Conclusions: Vaginal-rectal colonization with group A streptococci is rare, arguing against the
need for establishing group A streptococcal screening programs in pregnancy. An approach for
managing this uncommon finding is presented. Infect. Dis. Obstet. Gynecol. 8:217-219, 2000.
(C) 2000 Wiley-Liss, Inc.
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lthough group B streptococci (GBS) have been
described as common members of the vaginal
flora for over 60 years, vaginal colonization with
group A streptococci (GAS) has been reported in-
frequently. Because of recent concern over the in-
creasing incidence of severe, invasive GAS infec-
tions, questions have been raised regarding the
value of instituting antepartum screening programs
for GAS. Knowledge of GAS colonization rates in
late pregnancy would help to inform these discus-
sions.
In 1996 the Centers for Disease Control and
Prevention (CDC) issued guidelines for prevention
of group B streptococcal neonatal sepsis, including
recommendations for vaginal-rectal screening cul-
tures for GBS at 35-37 weeks of gestation. At the
University of Vermont/Fletcher Allen Health Care,
this protocol was reliably in place by late 1996, and
the laboratory methods used included testing of all
presumptive beta-hemolytic colonies for both
group A and group B antigen, allowing us to report
our 3 year experience with vaginal GAS coloniza-
tion in late pregnancy.
SUBJECTS AND METHODS
UVM/FAHC Medical Center, the only hospital in
Vermont’s largest city, performs approximately
2,300 deliveries annually. Patients are drawn from
all of the private practices, faculty practices, and
clinics in Chittenden County. Beginning in the fall
of 1996, all patients underwent a 35-37 week vagi-
nal-rectal screening culture for GBS as recom-
mended in the CDC culture-based protocol.
Rayon-tipped swabs of the vaginal introitus and
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anorectum were sent to the on-site laboratory in a
nonnutritive moist swab transport system (Cul-
turette II; Becton Dickinson, Sparks, MD). The
vaginal/rectal swabs were inoculated onto sheep
blood agar, colistin-naladixic acid agar, and into se-
lective Todd-Hewitt broth (Lira broth). After in-
cubation, the broth was subcultured to an addi-
tional sheep blood agar plate, unless group B beta
hemolytic streptococci had been identified on the
primary plates. This subcultured plate was incu-
bated for an additional 24 hr. All beta-hemolytic
streptococci were tested for group A and group B
antigens using slide agglutination (Streptex; Ab-
bott Laboratories, Abbott Park, IL).
We reviewed all 35-37 week screening cultures
obtained from January 1, 1997, through February
29, 2000, for isolations of GAS and GBS. Medical
records of patients with positive GAS isolations
were reviewed for management and outcome.
RESULTS
Six thousand nine hundred forty-four 35-37 week
vaginal-rectal screening cultures were obtained
during the 38 month study period. Among these,
1,393 were positive for GBS and 2 were positive for
GAS, yielding colonization rates of 20.1% for GBS
and 0.03% for GAS.
The two positive GAS cultures were obtained in
March, 1997, and February, 2000. Both patients
were GBS-negative. Neither received antepartum
treatment, and both received standard GBS intra-
partum prophylaxis with penicillin. Neither of the
mothers or infants became infected.
DISCUSSION
For this population, during the time period stud-
ied, 35-37 week vaginal-rectal colonization with
GAS was extremely uncommon, occurring only
once in every 3,472 deliveries. Larsenz has re-
viewed the literature pertaining to the microbiol-
ogy of the female genital tract and concluded that
"only rarely" are GAS stable members of the nor-
mal vaginal flora. A classic study of cervical flora
during pregnancy and the puerperium found no
group A beta-hemolytic streptococci, supporting
the concept that these organisms rarely colonize
the lower genital tract) To our knowledge, ours is
the first study to determine systematically the vagi-
nal-rectal GAS colonization rate in a large number
ofwomen in late pregnancy. Validation of the rarity
of GAS colonization is important, we believe; it
argues against the need for development of GAS
screening programs in pregnancy.
This is a northern New England population of
diverse socioeconomic status who are almost exclu-
sively white. Whether these results are generaliz-
able to other populations is unknown. Orogenital
sex is a postulated mechanism for female genital
tract colonization with GAS. We have no data on
the frequency of this practice in our population but
have no reason to suspect it differs widely from that
among other predominantly white U.S. popula-
tions. Oral sex is known to be less common among
nonwhite populations, and multivariate analyses
confirm the independent effect of race on this prac-
tice.4 If this indeed is an important mechanism for
female genital colonization, our mostly white popu-
lation might be expected to have a higher inci-
dence of colonization with GAS. The colonization
rate for GBS in this study, 20.1%, is well within the
rates of 18-26% reported by other investigators.5-7
Perinatally acquired infection from GAS has
been described infrequently,
8 a fact that is not sur-
prising given the low colonization rate described
here. Most infectious disease authorities view GAS
as a greater threat than GBS for the initiation of
infection, and, as noted above, question whether it
ever can be considered as "normal flora." The in-
creasing frequency of potentially catastrophic inva-
sive GAS infections, including streptococcal toxic
shock syndrome and necrotizing fasciitis,9-13 ar-
gues for thoughtfulness in responding to the iden-
tification of GAS from any culture, including that
from the lower genital tract. Until more data are
available, we have recently instituted a policy of
treating all positive GAS 35-37 week rectovaginal
screening cultures (pcnicillin-VK 500 mg p.o. QID
x l0 days) and performing a test-of-cure culture. In
addition, standard intrapartum prophylaxis with
penicillin G is used. Although this is not evidence-
based, it may provide prophylaxis against a serious
invasive GAS infection, and the infrequency of use
would seem to obviate concerns for antibiotic se-
lection pressure. In summary, we have docu-
mented that vaginal-rectal colonization with GAS
in late pregnancy is a rare event, and we conclude
that establishing GAS screening programs in preg-
nancy is not warranted.
218 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGYGROUP A STREPTOCOCCI MEAD AND WINN
REFERENCES
1. Centers for Disease Control. Prevention of perinatal
group B streptococcal disease: a public health perspec-
tive. MMWR 1996;45(RR-7): 1-24.
2. Larsen B. Microbiology of the female genital tract. In:
Pastorek JG, editor. Obstetric and gynecologic infec-
tious disease. New York: Raven Press; 1994. p 11-25.
3. Goplerud CP, Ohm MJ, Galask RP. Aerobic and anaero-
bic flora of the cervix during pregnancy and the puer-
perium. Am J Obstet Gynecol 1976;126:858-868.
4. Laumann EO, Gagnon JH, Michael RT, Michaels S.
The social organization of sexuality. Chicago: The Uni-
versity of Chicago Press; 1994. p 98.
5. Yancey MK, Duff P, Clark P, Kurtzer T, Frentzen BH,
Kubilis P. Peripartum infection associated with vaginal
group B streptococcal colonization. Obstet Gynecol
1994;84:816-819.
6. Yancey MK, Schuchat A, Brown LK, Ventura VL,
Markenson GR. The accuracy of late antenatal screen-
ing cultures in predicting genital group B streptococcal
colonization at delivery. Obstet Gynecol 1996;88:811-
815.
7. Regan JA, Klebanoff MA, Nugent RP. The epidemiol-
ogy of group B streptococcal colonization in pregnancy.
Obstet Gynecol 1991;77:604-610.
8. Panaro NR, Lutwick LI, Chapnick EK. Intrapartum
transmission of group A streptococcus. Clin Infect Dis
1993;17:79-81.
9. Dotters DJ, Katz VL. Streptococcal toxic shock associ-
ated with septic abortion. Obstet Gynecol 1991;78:549-
551.
10. Silver RM, Heddleston LN, McGregor JA, Gibbs RS.
Life-threatening infection due to group A streptococci.
Obstet Gynecol 1992;79:894-896.
11. Nathan L, Peters MT, Ahmed AM, Leveno KJ. The
return of life-threatening puerperal sepsis caused by
group A streptococci. Am Obstet Gynecol 1993;169:
571-572.
12. Rowan JA, North RA. Necrotizing fasciitis in the puer-
perium. Am J Obstet Gynecol 1995;173:241-242.
13. Udagawa H, Oshio Y, Shimizu Y. Serious group A strep-
tococcal infection around delivery. Obstet Gynecol
1999;94:153-157.
INFECTIOUS DISEASES 1N OBSTETRICS AND GYNECOLOGY 219